{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T13:09:33Z","timestamp":1779887373690,"version":"3.53.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:00:00Z","timestamp":1779840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:00:00Z","timestamp":1779840000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007102","name":"Zagazig University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007102","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Overactive bladder (OAB) is a common chronic condition that can have a significant impact on quality of life (HRQL). We aimed to assess the prevalence of OAB bother and its related quality of life among medical students in Egypt. A cross-sectional study among medical students in Egypt. An online questionnaire was shared via online platforms to collect the intended participants. We used the Overactive Bladder Symptoms and Health-Related Quality of Life Short Form (OAB-q SF). We assessed the difference between participants in their baseline characteristics using the Mann\u2013Whitney U and Kruskal\u2013Wallis Tests. We performed a multiple linear regression to assess the potential risk factors. 1003 participants completed the questionnaire. The median transformed OAB bother score was 10[3.33, 23.33], while the median transformed score of HRQL was 93.8[80, 98.46]. The prevalence was about 15%, while about 51.65% reported a decline in HRQL. A statistically significant association between OAB bother and academic phase, energy drink, or satisfaction with social life was reported. We found no association between OAB bother and caffeinated drinks or smoking. Finally, neither age, gender, nor BMI had an association with OAB bother. A low prevalence of OAB among medical students was found. Consumption of Energy drinks was found to be a risk factor, while caffeinated drinks had no effect. OAB was found to be higher in the academic phase than in the clinical one. Several studies should be conducted to further assess the risk factors of overactive bladder.<\/jats:p>\n                  <jats:p>Clinicaltrials.gov registration: NCT07044778, June 2025.<\/jats:p>","DOI":"10.1038\/s41598-026-53181-4","type":"journal-article","created":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T12:46:12Z","timestamp":1779885972000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prevalence and risk factors of overactive bladder syndrome among Egyptian medical students, and its impact on health-related quality of life, cross-sectional study"],"prefix":"10.1038","volume":"16","clinical-trial-number":[{"clinical-trial-number":"nct07044778","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-2991-4090","authenticated-orcid":false,"given":"Ahmed Fayez","family":"Mohamed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-1392-3505","authenticated-orcid":false,"given":"Abdelmonam M.","family":"Hagag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-8697-1907","authenticated-orcid":false,"given":"May Mahmoud","family":"Elgamal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-6143-1414","authenticated-orcid":false,"given":"Ibrahim Essam","family":"Elshaikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-7280-1939","authenticated-orcid":false,"given":"Asmaa Hamdy","family":"Abdellatif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-8001-1585","authenticated-orcid":false,"given":"Abdullah","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed M.","family":"Eliwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,27]]},"reference":[{"key":"53181_CR1","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1097\/AOG.0000000000003611","volume":"135","author":"HA Al","year":"2020","unstructured":"Al, H. A., Awamlh, B., Al Hussein Alawamlh, O., Lee, R. & Lee, U. J. Overactive bladder: Clinical updates in women\u2019s health care primary and preventive care review. Obstet. Gynecol. 135, 253. https:\/\/doi.org\/10.1097\/AOG.0000000000003611 (2020).","journal-title":"Obstet. Gynecol."},{"key":"53181_CR2","doi-asserted-by":"publisher","DOI":"10.1097\/JU.0000000000003985","author":"AP Cameron","year":"2024","unstructured":"Cameron, A. P. et al. The AUA\/SUFU guideline on the diagnosis and treatment of idiopathic overactive bladder. J. Urol. https:\/\/doi.org\/10.1097\/JU.0000000000003985 (2024).","journal-title":"J. Urol."},{"key":"53181_CR3","doi-asserted-by":"publisher","unstructured":"Raju, R. & Linder, B. J. Evaluation and treatment of overactive bladder in women. Mayo Clin Proc. 95, 370\u2013377. https:\/\/doi.org\/10.1016\/j.mayocp.2019.11.024 (2020).","DOI":"10.1016\/j.mayocp.2019.11.024"},{"key":"53181_CR4","unstructured":"Overactive bladder. ICS. https:\/\/www.ics.org\/public\/factsheets\/overactivebladder (accessed 6 Apr 2026)."},{"key":"53181_CR5","doi-asserted-by":"crossref","unstructured":"Abrams, P. et al. The standardization of terminology of lower urinary tract function: Report from the standardization sub-committee of international continence society. Textb. Female Urol. Urogynecol. 1098\u20131108 (2010).","DOI":"10.3109\/9781439807217-110"},{"key":"53181_CR6","doi-asserted-by":"publisher","first-page":"886782","DOI":"10.3389\/fphys.2022.886782","volume":"13","author":"KJ Mansfield","year":"2022","unstructured":"Mansfield, K. J., Chen, Z., Moore, K. H. & Grundy, L. Urinary tract infection in overactive bladder: An update on pathophysiological mechanisms. Front. Physiol. 13, 886782. https:\/\/doi.org\/10.3389\/fphys.2022.886782 (2022).","journal-title":"Front. Physiol."},{"key":"53181_CR7","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1002\/nau.23513","volume":"37","author":"E Durden","year":"2018","unstructured":"Durden, E. et al. The economic burden of overactive bladder (OAB) and its effects on the costs associated with other chronic, age-related comorbidities in the United States. Neurourol. Urodyn. 37, 1641\u20131649. https:\/\/doi.org\/10.1002\/nau.23513 (2018).","journal-title":"Neurourol. Urodyn."},{"key":"53181_CR8","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1002\/nau.23477","volume":"37","author":"LC Powell","year":"2018","unstructured":"Powell, L. C., Szabo, S. M., Walker, D. & Gooch, K. The economic burden of overactive bladder in the United States: A systematic literature review. Neurourol. Urodyn. 37, 1241\u20131249. https:\/\/doi.org\/10.1002\/nau.23477 (2018).","journal-title":"Neurourol. Urodyn."},{"key":"53181_CR9","doi-asserted-by":"publisher","first-page":"11","DOI":"10.2147\/rru.s4166","volume":"2","author":"E Sacco","year":"2010","unstructured":"Sacco, E. et al. Social, economic, and health utility considerations in the treatment of overactive bladder. OPEN. Access. J. Urol. 2, 11\u201324. https:\/\/doi.org\/10.2147\/rru.s4166 (2010).","journal-title":"OPEN. Access. J. Urol."},{"key":"53181_CR10","doi-asserted-by":"publisher","first-page":"16284","DOI":"10.1038\/s41598-024-66758-8","volume":"14","author":"Y Cheng","year":"2024","unstructured":"Cheng, Y. et al. Prevalence and trends in overactive bladder among men in the United States, 2005\u20132020. Sci. Rep. 14, 16284. https:\/\/doi.org\/10.1038\/s41598-024-66758-8 (2024).","journal-title":"Sci. Rep."},{"issue":"Suppl 3","key":"53181_CR11","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1002\/nau.22636","volume":"33","author":"F Haab","year":"2014","unstructured":"Haab, F. Chapter 1: The conditions of neurogenic detrusor overactivity and overactive bladder. Neurourol. Urodyn. 33 (Suppl 3), S2\u20135. https:\/\/doi.org\/10.1002\/nau.22636 (2014).","journal-title":"Neurourol. Urodyn."},{"key":"53181_CR12","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1002\/nau.24894","volume":"41","author":"J Santander","year":"2022","unstructured":"Santander, J. et al. What is the real burden of the overactive bladder? Results from a national prevalence study. Neurourol. Urodyn. 41, 926\u2013934. https:\/\/doi.org\/10.1002\/nau.24894 (2022).","journal-title":"Neurourol. Urodyn."},{"key":"53181_CR13","doi-asserted-by":"publisher","first-page":"19819","DOI":"10.1038\/s41598-020-76846-0","volume":"10","author":"M Przydacz","year":"2020","unstructured":"Przydacz, M., Golabek, T., Dudek, P., Lipinski, M. & Chlosta, P. Prevalence and bother of lower urinary tract symptoms and overactive bladder in Poland, an eastern European study. Sci. Rep. 10, 19819. https:\/\/doi.org\/10.1038\/s41598-020-76846-0 (2020).","journal-title":"Sci. Rep."},{"key":"53181_CR14","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1080\/2090598X.2023.2221403","volume":"22","author":"S Qudah","year":"2024","unstructured":"Qudah, S. et al. The prevalence of overactive bladder and its impact on the quality of life: A cross-sectional study. Arab. J. Urol. 22, 39\u201347. https:\/\/doi.org\/10.1080\/2090598X.2023.2221403 (2024).","journal-title":"Arab. J. Urol."},{"key":"53181_CR15","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12894-023-01394-4","volume":"24","author":"S Abuorouq","year":"2024","unstructured":"Abuorouq, S. et al. The prevalence of probable overactive bladder and associated risk factors among medical students in Jordan: A cross-sectional study. BMC Urol. 24, 7. https:\/\/doi.org\/10.1186\/s12894-023-01394-4 (2024).","journal-title":"BMC Urol."},{"key":"53181_CR16","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s12894-021-00909-1","volume":"21","author":"R Shawahna","year":"2021","unstructured":"Shawahna, R., Hijaz, H., Jallad, K., Abushamma, M. & Sawafta, M. Prevalence of overactive bladder symptoms and their impact on health-related quality of life of medical and dentistry students: A multicenter cross-sectional study. BMC Urol. 21, 142. https:\/\/doi.org\/10.1186\/s12894-021-00909-1 (2021).","journal-title":"BMC Urol."},{"key":"53181_CR17","doi-asserted-by":"publisher","first-page":"573","DOI":"10.7326\/0003-4819-147-8-200710160-00010","volume":"147","author":"E von Elm","year":"2007","unstructured":"von Elm, E. et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Ann. Intern. Med. 147, 573\u2013577. https:\/\/doi.org\/10.7326\/0003-4819-147-8-200710160-00010 (2007).","journal-title":"Ann. Intern. Med."},{"key":"53181_CR18","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1002\/nau.22559","volume":"34","author":"KS Coyne","year":"2015","unstructured":"Coyne, K. S., Thompson, C. L., Lai, J-S. & Sexton, C. C. An overactive bladder symptom and health-related quality of life short-form: Validation of the OAB-q SF: Validation of the OAB-q SF. Neurourol. Urodyn. 34, 255\u2013263. https:\/\/doi.org\/10.1002\/nau.22559 (2015).","journal-title":"Neurourol. Urodyn."},{"key":"53181_CR19","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.juro.2007.03.133","volume":"178","author":"JG Blaivas","year":"2007","unstructured":"Blaivas, J. G., Panagopoulos, G., Weiss, J. P. & Somaroo, C. Validation of the overactive bladder symptom score. J. Urol. 178, 543\u2013547. https:\/\/doi.org\/10.1016\/j.juro.2007.03.133 (2007).","journal-title":"J. Urol."},{"key":"53181_CR20","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/ageing\/afi205","volume":"35","author":"CW McGrother","year":"2006","unstructured":"McGrother, C. W. et al. Urinary storage symptoms and comorbidities: A prospective population cohort study in middle-aged and older women. Age Ageing. 35, 16\u201324. https:\/\/doi.org\/10.1093\/ageing\/afi205 (2006).","journal-title":"Age Ageing"},{"key":"53181_CR21","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.ejogrb.2012.06.006","volume":"164","author":"A \u00d6zg\u00fcr Yeniel","year":"2012","unstructured":"\u00d6zg\u00fcr Yeniel, A. et al. The prevalence of probable overactive bladder, associated risk factors and its effect on quality of life among Turkish midwifery students. Eur. J. Obstet. Gynecol. Reprod. Biol. 164, 105\u2013109. https:\/\/doi.org\/10.1016\/j.ejogrb.2012.06.006 (2012).","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"53181_CR22","doi-asserted-by":"publisher","first-page":"342","DOI":"10.5213\/inj.2244188.094","volume":"26","author":"Y Liang","year":"2022","unstructured":"Liang, Y. et al. Prevalence, risk factors, and psychological effects of overactive bladder in Chinese University Students. Int. Neurourol. J. 26, 342\u2013348. https:\/\/doi.org\/10.5213\/inj.2244188.094 (2022).","journal-title":"Int. Neurourol. J."},{"key":"53181_CR23","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1111\/j.1464-410X.2008.07573.x","volume":"101","author":"DE Irwin","year":"2008","unstructured":"Irwin, D. E. et al. Understanding the elements of overactive bladder: questions raised by the EPIC study. BJU Int. 101, 1381\u20131387. https:\/\/doi.org\/10.1111\/j.1464-410X.2008.07573.x (2008).","journal-title":"BJU Int."},{"key":"53181_CR24","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/j.1464-410X.2009.08438.x","volume":"103 Suppl 3","author":"KS Coyne","year":"2009","unstructured":"Coyne, K. S. et al. Risk factors and comorbid conditions associated with lower urinary tract symptoms: EpiLUTS. BJU Int. 103 Suppl 3, 24\u201332. https:\/\/doi.org\/10.1111\/j.1464-410X.2009.08438.x (2009).","journal-title":"BJU Int."},{"key":"53181_CR25","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.urology.2012.04.004","volume":"80","author":"I Milsom","year":"2012","unstructured":"Milsom, I., Kaplan, S. A., Coyne, K. S., Sexton, C. C. & Kopp, Z. S. Effect of bothersome overactive bladder symptoms on health-related quality of life, anxiety, depression, and treatment seeking in the United States: Results from EpiLUTS. Urology 80, 90\u201396. https:\/\/doi.org\/10.1016\/j.urology.2012.04.004 (2012).","journal-title":"Urology"},{"key":"53181_CR26","doi-asserted-by":"publisher","first-page":"5112405","DOI":"10.1155\/2024\/5112405","volume":"2024","author":"A Wagg","year":"2024","unstructured":"Wagg, A., Ackerman, A. L., Lai, H. H. & Newman, D. K. Review of the impact and burden of urinary urgency on adults with overactive bladder. Int. J. Clin. Pract. 2024, 5112405. https:\/\/doi.org\/10.1155\/2024\/5112405 (2024).","journal-title":"Int. J. Clin. Pract."},{"key":"53181_CR27","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1016\/j.urology.2014.07.014","volume":"84","author":"SA Mitchell","year":"2014","unstructured":"Mitchell, S. A. et al. Evaluating patients\u2019 symptoms of overactive bladder by questionnaire: the role of urgency in urinary frequency. Urology 84, 1039\u20131043. https:\/\/doi.org\/10.1016\/j.urology.2014.07.014 (2014).","journal-title":"Urology"},{"key":"53181_CR28","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.maturitas.2014.06.009","volume":"79","author":"D Robinson","year":"2014","unstructured":"Robinson, D., Giarenis, I. & Cardozo, L. You are what you eat: The impact of diet on overactive bladder and lower urinary tract symptoms. Maturitas 79, 8\u201313. https:\/\/doi.org\/10.1016\/j.maturitas.2014.06.009 (2014).","journal-title":"Maturitas"},{"key":"53181_CR29","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1002\/nau.23149","volume":"36","author":"D Robinson","year":"2017","unstructured":"Robinson, D., Hanna-Mitchell, A., Rantell, A., Thiagamoorthy, G. & Cardozo, L. Are we justified in suggesting change to caffeine, alcohol, and carbonated drink intake in lower urinary tract disease? Report from the ICI\u2010RS 2015. Neurourol. Urodyn. 36, 876\u2013881. https:\/\/doi.org\/10.1002\/nau.23149 (2017).","journal-title":"Neurourol. Urodyn."},{"key":"53181_CR30","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1016\/j.juro.2008.07.042","volume":"180","author":"R Shiri","year":"2008","unstructured":"Shiri, R. et al. The effects of lifestyle factors on the incidence of nocturia. J. Urol. 180, 2059\u20132062. https:\/\/doi.org\/10.1016\/j.juro.2008.07.042 (2008).","journal-title":"J. Urol."},{"key":"53181_CR31","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1016\/j.juro.2017.04.097","volume":"198","author":"CS Bradley","year":"2017","unstructured":"Bradley, C. S. et al. Evidence of the impact of diet, fluid intake, caffeine, alcohol and tobacco on lower urinary tract symptoms: A systematic review. J. Urol. 198, 1010\u20131020. https:\/\/doi.org\/10.1016\/j.juro.2017.04.097 (2017).","journal-title":"J. Urol."},{"key":"53181_CR32","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1093\/aje\/kwp133","volume":"170","author":"KAO Tikkinen","year":"2009","unstructured":"Tikkinen, K. A. O. et al. A systematic evaluation of factors associated with nocturia\u2014The population-based FINNO study. Am. J. Epidemiol. 170, 361\u2013368. https:\/\/doi.org\/10.1093\/aje\/kwp133 (2009).","journal-title":"Am. J. Epidemiol."},{"key":"53181_CR33","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1111\/j.1532-5415.2011.03492.x","volume":"59","author":"CC Sexton","year":"2011","unstructured":"Sexton, C. C. et al. Prevalence and effect on health-related quality of life of overactive bladder in older Americans: Results from the epidemiology of lower urinary tract symptoms study. J. Am. Geriatr. Soc. 59, 1465\u20131470. https:\/\/doi.org\/10.1111\/j.1532-5415.2011.03492.x (2011).","journal-title":"J. Am. Geriatr. Soc."},{"key":"53181_CR34","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1111\/j.1524-4733.2004.74008.x","volume":"7","author":"KS Coyne","year":"2004","unstructured":"Coyne, K. S. et al. The impact of urinary urgency and frequency on health-related quality of life in overactive bladder: results from a national community survey. Value Health J. Int. Soc. Pharmacoecon. Outcomes Res. 7, 455\u2013463. https:\/\/doi.org\/10.1111\/j.1524-4733.2004.74008.x (2004).","journal-title":"Value Health J. Int. Soc. Pharmacoecon. Outcomes Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-53181-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-53181-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-53181-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T12:46:14Z","timestamp":1779885974000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-53181-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,27]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["53181"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-53181-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,27]]},"assertion":[{"value":"6 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was conducted in accordance with the ethical principles of the Declaration of Helsinki. Ethical approval was obtained from the institutional review board (IRB) of Zagazig University faculty of medicine under the code: ZU-IRB # 1328 \/18-May-2025.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Before the commencement of the study, informed consent was obtained from each participant. They were informed about the aim of the study, the procedures involved, and any risks or benefits of the study. Also, they were informed that the study was conducted in accordance with the ethical principles of the Declaration of Helsinki. Finally, they were informed that they could withdraw at any time from the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for participation"}}],"article-number":"16437"}}